JXX Janus Detroit Street Trust - Janus Henderson Transformational Growth ETF
Quote as of Oct 26, 2026 14:11 UTC · Quotes are refreshed hourly from the data provider, so during market hours a price can be up to about 1–2 hours old; each quote shows its own timestamp.
| Previous Close | 28.69 | Day Range | 28.47 – 28.69 |
| 52-Week Range | 23.64 – 33.61 | Volume | 20 |
| Avg Volume | 1.44K | AUM | $21.5M (Oct 26, 2026) |
| Expense Ratio | 0.57% | Yield (TTM) | — |
| NAV | 28.70 | Premium/Discount | -0.14% indicative |
| Inception | Feb 04, 2025 | Holdings | 24 |
| Issuer | Janus Henderson | Exchange | CBOE |
| Category | Emerging Markets | Index Tracked | Not stated in source data |
| CUSIP | 47103U696 | ISIN | US47103U6964 |
| Management | Not stated in source data | ||
About this ETF
JXX employs a focused investment strategy by maintaining a portfolio of around 20 to 30 equity securities, primarily consisting of larger, well-established companies across various sectors, while allowing for the inclusion of foreign securities listed on US exchanges. The fund integrates a bottom-up approach centered on fundamental analysis with a top-down thematic perspective, targeting companies that demonstrate sustainable competitive advantages and long-term growth potential. Investment themes include developments in artificial intelligence, cloud computing, digitization, and healthcare innovation, which may be adjusted as societal trends evolve. The fund actively monitors portfolio holdings, evaluating them for sale if there is deterioration in financial health or a shift in the investment thesis. Overall, the objective remains focused on long-term capital appreciation, with additional income generation pursued through securities lending activities.
Description from the fund data provider · profile as of Oct 26, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -9.09% | -4.56% | -1.31% | +2.46% | +1.74% | — | — | — | +7.48% |
| Total return | -9.09% | -4.56% | -1.31% | +2.46% | +1.74% | — | — | — | +7.50% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 23, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.57% | Annual cost of a $10,000 investment | $57.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings list retrieved Oct 24, 2026 · The data provider's latest disclosed portfolio for this fund. Issuers publish holdings daily or monthly, so the portfolio date can be earlier; holdings are not live positions. 24 holdings stored.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co., Ltd.… | TSM | 11.88% | 6.11K | $2.6M |
| 2 | Amazon.com, Inc. | AMZN | 8.30% | 7.21K | $1.8M |
| 3 | Oracle Corporation | ORCL | 7.41% | 12.65K | $1.6M |
| 4 | Broadcom Inc. | AVGO | 6.35% | 4.25K | $1.4M |
| 5 | Danaher Corporation | DHR | 4.89% | 4.56K | $1.1M |
| 6 | UnitedHealth Group Incorporated | UNH | 4.72% | 2.43K | $1.0M |
| 7 | Howmet Aerospace Inc. | HWM | 4.43% | 5.13K | $953.2K |
| 8 | Advanced Micro Devices, Inc. | AMD | 4.40% | 1.83K | $947.3K |
| 9 | Boeing Company | BA | 4.30% | 4.92K | $926.7K |
| 10 | Datadog, Inc. Class A | DDOG | 4.11% | 3.28K | $885.3K |
| 11 | Eli Lilly and Company | LLY | 4.08% | 689 | $877.4K |
| 12 | Forgent Power Solutions, Inc. Class A | FPS | 3.85% | 34.22K | $828.8K |
| 13 | Lumentum Holdings, Inc. | LITE | 3.80% | 1.08K | $817.4K |
| 14 | MercadoLibre, Inc. | MELI | 3.58% | 426 | $771.1K |
| 15 | Vaxcyte, Inc. | PCVX | 3.10% | 11.05K | $667.6K |
| 16 | Madrigal Pharmaceuticals, Inc. | MDGL | 2.99% | 1.48K | $644.4K |
| 17 | Nebius Group N.V. Class A | NBIS | 2.69% | 3.65K | $580.0K |
| 18 | Intercontinental Exchange, Inc. | ICE | 2.64% | 3.49K | $568.3K |
| 19 | Robinhood Markets, Inc. Class A | HOOD | 2.56% | 5.80K | $551.6K |
| 20 | DoorDash, Inc. Class A | DASH | 2.56% | 3.07K | $551.4K |
| 21 | DraftKings, Inc. Class A | DKNG | 2.36% | 24.31K | $508.4K |
| 22 | US DOLLARS | — | 1.84% | 396.59K | $396.6K |
| 23 | Legence Corp. Class A | LGN | 1.62% | 9.64K | $347.8K |
| 24 | Revolution Medicines, Inc. | RVMD | 1.53% | 1.76K | $328.4K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Jun 30, 2025 | Last payment | $0.0040 (Jul 07, 2025) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 30, 2025 | Jun 30, 2025 | Jul 07, 2025 | $0.0040 |
| Mar 31, 2025 | Mar 31, 2025 | Apr 04, 2025 | $0.0080 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 24.07% / — | Sharpe 1Y / 3Y | -0.14 / — |
| Max drawdown 1Y / 3Y | -18.02% / — | Sortino 1Y | -0.194 |
| Beta vs S&P 500 (3Y) | 1.24 | Correlation vs S&P 500 (1Y) | 0.837 |
| Downside deviation 1Y | 17.39% | Risk-free rate used | 4.04% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 26, 2026. Formulas →
Liquidity
| Volume today | 20 | Average volume | 1.44K |
| AUM | $21.5M | Premium/Discount | -0.14% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Week | $12.2K | +0.06% | $22.1M → $21.5M |
| 1 Month | $780.4K | +3.40% | $22.9M → $21.5M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for JXX
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.